These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20050879)

  • 21. Outcomes, Interventions and Funding in Randomised Research Published in High-Impact Journals.
    Grey P; Grey A; Bolland MJ
    Trials; 2018 Oct; 19(1):592. PubMed ID: 30373636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials.
    Pang WK; Yeter KC; Torralba KD; Spencer HJ; Khan NA
    Int J Rheum Dis; 2015 Jul; 18(6):606-15. PubMed ID: 26012523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry.
    Perlis RH; Perlis CS; Wu Y; Hwang C; Joseph M; Nierenberg AA
    Am J Psychiatry; 2005 Oct; 162(10):1957-60. PubMed ID: 16199844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sponsorship bias in clinical research.
    Lexchin J
    Int J Risk Saf Med; 2012; 24(4):233-42. PubMed ID: 23135338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An updated survey for the 2007-2013 period of randomized controlled trials for psoriasis: treatment modalities, study designs, comparators, outcome measures and sponsorship.
    Manalo IF; Gilbert KE; Wu JJ
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1945-50. PubMed ID: 25763768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of industry sponsorship on the reporting of subgroup analyses within phase III randomised controlled trials in gastrointestinal oncology.
    Barton S; Peckitt C; Sclafani F; Cunningham D; Chau I
    Eur J Cancer; 2015 Dec; 51(18):2732-9. PubMed ID: 26608121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sponsors' participation in conduct and reporting of industry trials: a descriptive study.
    Lundh A; Krogsbøll LT; Gøtzsche PC
    Trials; 2012 Aug; 13():146. PubMed ID: 22920226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Making available information from studies sponsored by the pharmaceutical industry: some current practices.
    O'Kelly M; Julious SA; Pyke S; Day S; Todd S; Seldrup J; Matcham J
    Pharm Stat; 2011; 10(1):60-9. PubMed ID: 21275036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized trials assessing calcium supplementation in healthy children: relationship between industry sponsorship and study outcomes.
    Nkansah N; Nguyen T; Iraninezhad H; Bero L
    Public Health Nutr; 2009 Oct; 12(10):1931-7. PubMed ID: 19254426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.
    Califf RM; Zarin DA; Kramer JM; Sherman RE; Aberle LH; Tasneem A
    JAMA; 2012 May; 307(17):1838-47. PubMed ID: 22550198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The uncertainty principle and industry-sponsored research.
    Djulbegovic B; Lacevic M; Cantor A; Fields KK; Bennett CL; Adams JR; Kuderer NM; Lyman GH
    Lancet; 2000 Aug; 356(9230):635-8. PubMed ID: 10968436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmaceutical industry sponsorship and research outcome and quality: systematic review.
    Lexchin J; Bero LA; Djulbegovic B; Clark O
    BMJ; 2003 May; 326(7400):1167-70. PubMed ID: 12775614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of study sponsorship on head and neck cancer randomized trial results.
    Sun GH; Houlton JJ; MacEachern MP; Bradford CR; Hayward RA
    Head Neck; 2013 Oct; 35(10):1515-20. PubMed ID: 22987508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conflict of interest in industry-sponsored economic evaluations: real or imagined?
    Barbieri M; Drummond MF
    Curr Oncol Rep; 2001 Sep; 3(5):410-3. PubMed ID: 11489241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Authorship selection in industry-sponsored publications of dermatology clinical trials.
    Tauber M; Paul C
    Br J Dermatol; 2017 Jun; 176(6):1669-1671. PubMed ID: 28303566
    [No Abstract]   [Full Text] [Related]  

  • 36. Criteria for site selection in industry-sponsored clinical trials: a survey among decision-makers in biopharmaceutical companies and clinical research organizations.
    Dombernowsky T; Haedersdal M; Lassen U; Thomsen SF
    Trials; 2019 Dec; 20(1):708. PubMed ID: 31829234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled clinical trials and clinical patient-care: sometimes in conflict.
    Peloso PM; Riley ML
    Ann R Coll Physicians Surg Can; 1998 Dec; 31(8):372-4. PubMed ID: 12378740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sponsorship bias in the comparative efficacy of psychotherapy and pharmacotherapy for adult depression: meta-analysis.
    Cristea IA; Gentili C; Pietrini P; Cuijpers P
    Br J Psychiatry; 2017 Jan; 210(1):16-23. PubMed ID: 27810891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmaceutical company-sponsored drug trials: the system is broken.
    Gartlehner G; Fleg A
    J Clin Epidemiol; 2010 Feb; 63(2):128-9. PubMed ID: 19880288
    [No Abstract]   [Full Text] [Related]  

  • 40. Sponsorship of oncology clinical trials in the United States according to age of eligibility.
    Neel DV; Shulman DS; Ma C; Bourgeois F; DuBois SG
    Cancer Med; 2020 Jul; 9(13):4495-4500. PubMed ID: 32351000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.